Skincare company LABthetics will unveil its LABpen microneedling device at CCR in October.
The device is CE marked and approved by the US Food and Drug Administration (FDA). LABthetics explains that the device works with the LABthetics active serums to induce collagen therapy and aid the transepidermal penetration of active ingredients.
The LABpen has changeable headpieces which create micro-canals to deliver results. The device is an addition to a new line of microneedling products which include professional cleansers, toners, masks, and specialist serums, explains the company.
Emma Caine, founder of LABthetics, commented, “We are so excited for a CCR launch. We have been working hard on our microneedling product line and are excited to introduce this to new potential clients. The microneedling line complements our professional range perfectly with our chemical peels and clinical facials.”
CCR will take place on October 14-15 at ExCeL London.
